Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04826237
PHASE4

Oral Statins and Protection From Hearing Loss

Sponsor: Northwestern University

View on ClinicalTrials.gov

Summary

A small clinical trial for idiopathic sudden sensorineural hearing loss (ISSNHL). Will the addition of an oral statin to the standard treatment (oral methylprednesolone and the salvage therapy of intratympanic dexamethasone) improve the treatment outcome for patients with ISSNHL? This study will compare the two treatments and quantitatively evaluate hearing and speech discrimination and have the patients subjectively evaluate tinnitus.

Official title: Towards a Self-Administered Hearing Protection Regimen

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2023-02-09

Completion Date

2025-12-31

Last Updated

2024-12-05

Healthy Volunteers

No

Interventions

DRUG

Statin

Oral dose to be taken with methylprednisolone

DRUG

methylprednisolone

oral dose, standard of care

DRUG

dexamethasone

Drug for intratympanic administration

DRUG

Placebo

Capsule the same as for statins but without statin

Locations (1)

Northwestern Memorial Hospital

Chicago, Illinois, United States